Macleods wins appeal against Boehringer in Indian court over patent revocation
Macleods Pharmaceuticals has secured an Indian court order allowing it to continue pursuing the revocation of Boehringer Ingelheim Pharma’s expired Linagliptin patent. Macleods Pharmaceuticals can continue its bid to revoke Boehringer...To view the full article, register now.
Already a subscriber? Click here to view full article